Poly Medicure Future Growth
Future criteria checks 4/6
Poly Medicure is forecast to grow earnings and revenue by 24% and 19.5% per annum respectively. EPS is expected to grow by 23.4% per annum. Return on equity is forecast to be 19.7% in 3 years.
Key information
24.0%
Earnings growth rate
23.4%
EPS growth rate
Medical Equipment earnings growth | 21.1% |
Revenue growth rate | 19.5% |
Future return on equity | 19.7% |
Analyst coverage | Low |
Last updated | 17 Oct 2024 |
Recent future growth updates
Recent updates
Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 20Poly Medicure (NSE:POLYMED) Will Pay A Dividend Of ₹3.00
Sep 14After Leaping 41% Poly Medicure Limited (NSE:POLYMED) Shares Are Not Flying Under The Radar
Sep 06Poly Medicure (NSE:POLYMED) Has A Pretty Healthy Balance Sheet
Aug 14Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹2,138
Jul 27Investors Still Waiting For A Pull Back In Poly Medicure Limited (NSE:POLYMED)
Jul 11Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2027 | 24,684 | 5,242 | 2,827 | N/A | 3 |
3/31/2026 | 20,716 | 4,306 | 1,856 | N/A | 5 |
3/31/2025 | 16,922 | 3,314 | 869 | N/A | 5 |
6/30/2024 | 14,397 | 2,696 | N/A | N/A | N/A |
3/31/2024 | 13,758 | 2,583 | -109 | 2,661 | N/A |
12/31/2023 | 13,046 | 2,487 | N/A | N/A | N/A |
9/30/2023 | 12,498 | 2,337 | -197 | 2,390 | N/A |
6/30/2023 | 11,872 | 2,150 | N/A | N/A | N/A |
3/31/2023 | 11,152 | 1,793 | -482 | 1,911 | N/A |
12/31/2022 | 10,659 | 1,566 | N/A | N/A | N/A |
9/30/2022 | 10,113 | 1,411 | -533 | 1,568 | N/A |
6/30/2022 | 9,600 | 1,359 | N/A | N/A | N/A |
3/31/2022 | 9,231 | 1,465 | -321 | 1,235 | N/A |
12/31/2021 | 8,785 | 1,492 | N/A | N/A | N/A |
9/30/2021 | 8,518 | 1,500 | -228 | 777 | N/A |
6/30/2021 | 8,280 | 1,468 | N/A | N/A | N/A |
3/31/2021 | 7,865 | 1,359 | 236 | 1,187 | N/A |
12/31/2020 | 7,448 | 1,197 | N/A | N/A | N/A |
9/30/2020 | 7,218 | 1,094 | 347 | 1,543 | N/A |
6/30/2020 | 6,960 | 1,028 | N/A | N/A | N/A |
3/31/2020 | 6,872 | 959 | 223 | 1,283 | N/A |
12/31/2019 | 6,881 | 947 | N/A | N/A | N/A |
9/30/2019 | 6,625 | 858 | 603 | 1,197 | N/A |
6/30/2019 | 6,388 | 719 | N/A | N/A | N/A |
3/31/2019 | 6,108 | 654 | 285 | 1,065 | N/A |
3/31/2018 | 5,204 | 706 | N/A | 750 | N/A |
3/31/2017 | 4,550 | 551 | N/A | 561 | N/A |
3/31/2016 | 4,123 | 483 | N/A | 632 | N/A |
3/31/2015 | 3,903 | 623 | N/A | 633 | N/A |
3/31/2014 | 3,222 | 451 | N/A | 661 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: POLYMED's forecast earnings growth (24% per year) is above the savings rate (6.7%).
Earnings vs Market: POLYMED's earnings (24% per year) are forecast to grow faster than the Indian market (17.4% per year).
High Growth Earnings: POLYMED's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: POLYMED's revenue (19.5% per year) is forecast to grow faster than the Indian market (10.1% per year).
High Growth Revenue: POLYMED's revenue (19.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: POLYMED's Return on Equity is forecast to be low in 3 years time (19.7%).